Gyde Acquires We Know Medicare as AI-Native Brokerage Race Accelerates

Gyde is moving aggressively through the Medicare brokerage market, and the latest signal is its acquisition of We Know Medicare. The Austin-based company, launched publicly with $60M in financing led by Lightspeed, is building what it calls an AI-native insurance brokerage platform centered on broker workflows, automation, and health insurance distribution. The acquisition adds another layer to Gyde’s broader strategy of pairing software infrastructure with established agency relationships. That matters because Medicare distribution is not a market won through flashy interfaces or generic automation claims. It is built on trust, local relationships, and operational endurance. Gyde appears to understand that better than a surprising number of companies currently trying to force healthcare into a self-service SaaS template.

Will Johnson, CEO and Co-Founder of Gyde, alongside COO and Co-Founder Sam Wiener, has positioned the company around a simple thesis: brokers are not disappearing, but the administrative burden around them needs to. The acquisition of We Know Medicare follows Gyde’s earlier expansion moves involving Avid Health and Benavest, reinforcing a strategy focused on acquiring distribution while modernizing the operational layer underneath it. That combination is becoming increasingly important as venture capital shifts toward AI infrastructure businesses with direct revenue pathways instead of speculative consumer engagement metrics dressed up as innovation. Healthcare brokerage happens to sit directly in that intersection: complex workflows, high-value relationships, and legacy systems still operating like PDFs became sentient and unionized.

What Happened

Gyde acquired We Know Medicare as part of its expanding Medicare brokerage strategy. Financial terms of the transaction were not publicly disclosed. The acquisition strengthens Gyde’s footprint in Medicare distribution while extending the reach of GydeOS and Gia, the company’s broker-focused operating system and AI assistant platform. Gyde has consistently framed its technology stack around helping brokers automate low-complexity administrative work while improving servicing, client engagement, onboarding, and cross-sell opportunities.

Leadership across the company reflects that operational focus. Andrew Shults, CTO at Gyde, is overseeing the technical architecture behind the platform, while Jonathan Hale, Head of Data, is helping shape the company’s intelligence and workflow systems. Griffin Collins, Head of Origination, is focused on agency expansion and acquisitions, while Nick Keeley, Head of Value Creation, and Michael Johns, Value Creation Director, are focused on operational scale inside acquired agencies. That structure says a lot about the company’s priorities. Gyde is not acting like a startup trying to manufacture attention through vague AI branding. The company is building distribution infrastructure inside one of healthcare’s most operationally fragmented markets.

Why This Matters

Medicare brokerage is messy, deeply human, and emotionally sensitive. Families are making decisions tied to prescriptions, physicians, finances, timing, and fear. One weak recommendation can create months of downstream consequences. That reality explains why independent brokers still hold enormous influence despite years of predictions that digital platforms would replace them. Consumers do not necessarily want fewer humans involved in healthcare decisions. They want fewer administrative nightmares.

Gyde’s thesis appears to center on that distinction. The company is not trying to eliminate brokers. It is trying to remove the repetitive operational drag surrounding brokers. That means meeting prep automation, communication workflows, onboarding support, renewal management, and identifying revenue opportunities across client relationships. Healthcare technology companies frequently underestimate how much operational exhaustion exists inside insurance distribution. Founders love talking about “consumer empowerment” right up until they discover enrollment workflows capable of psychologically damaging otherwise stable adults. Gyde seems more interested in workflow realism than conference-stage theater.

Market Context

The broader insurtech market has shifted dramatically over the past 24 months. Investors have become increasingly skeptical of companies that rely exclusively on customer acquisition economics without operational durability. That shift is pushing capital toward infrastructure-oriented healthcare businesses capable of combining software margins with embedded distribution. Gyde’s $60M financing round, led by Lightspeed with participation from Optum Ventures, Crystal Venture Partners, Virtue, MVP Ventures, and multiple endowment funds, reflects that trend directly.

This is no longer the era where simply attaching “AI-powered” to a brokerage pitch guarantees investor enthusiasm. The market has matured. Operators now need evidence of distribution, execution, and retention. Acquiring agencies like Avid Health, Benavest, and We Know Medicare gives Gyde something more valuable than temporary market attention. It gives the company existing trust networks and embedded customer relationships inside highly regulated healthcare markets. That matters because distribution remains one of the hardest problems in healthcare technology. Plenty of startups build software. Far fewer successfully build trust.

Competitive Landscape

Gyde is entering a crowded healthcare technology environment, but its positioning differs from many venture-backed insurtech competitors. A large portion of the market still approaches healthcare brokerage through direct-to-consumer acquisition models or generic SaaS tooling layered onto existing agencies. Gyde is taking a more integrated route by combining acquisitions, workflow automation, and broker infrastructure into a unified operating model.

The distinction is subtle but important. Instead of asking brokers to abandon existing relationships, Gyde appears focused on strengthening them through operational efficiency. That strategy may prove more resilient than purely transactional healthcare platforms chasing short-term enrollment spikes. Healthcare consumers rarely remember the software platform involved in a successful enrollment process. They remember the person who answered the phone when everything felt confusing.

What This Signals

Gyde’s acquisition strategy signals a broader shift happening across AI-enabled healthcare infrastructure. The next wave of AI companies may not look like traditional software startups at all. They may increasingly resemble operational businesses with deeply embedded workflows, distribution control, and specialized vertical infrastructure. Insurance brokerage happens to fit that model perfectly because the market is enormous, the workflows are fragmented, the operational inefficiencies are everywhere, and the human trust layer remains difficult to replace.

That combination creates a rare opportunity for companies capable of modernizing infrastructure without destroying the relationships underneath it. Gyde appears determined to test that thesis at full speed.